Little House Capital’s Boston Scientific BSX Stock Holding History

Little House Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,440	Closed	-$843K	–	114
2026 Q1	$843K	Buy	13,440 +67	+0.5%	+$5.36K	0.22%	89
2025 Q4	$1.28M	Buy	13,373 +3,443	+35%	+$338K	0.32%	68
2025 Q3	$969K	Buy	9,930 +141	+1%	+$14.6K	0.22%	92
2025 Q2	$1.05M	Buy	9,789 +424	+5%	+$42.9K	0.26%	85
2025 Q1	$945K	Buy	+9,365	New	+$943K	0.26%	87
2022 Q1	–	Sell	-6,865	Closed	-$292K	–	134
2021 Q4	$292K	Buy	6,865 +43	+0.6%	+$1.81K	0.15%	122
2021 Q3	$296K	Buy	6,822 +612	+10%	+$27.1K	0.17%	114
2021 Q2	$266K	Buy	+6,210	New	+$261K	0.14%	125

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Little House Capital's BSX Position: Q2 2026 in Review

Little House Capital sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 13,440 shares — an estimated $843K sold.

Little House Capital first reported a position in BSX in Q2 2021 and held it in 8 quarters. The position peaked at $1.28M in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Little House Capital reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Little House Capital sold 13,440 Boston Scientific shares in Q2 2026, an estimated $843K.
Little House Capital first reported a position in Boston Scientific in Q2 2021 and held it in 8 quarters.
Little House Capital's Boston Scientific position peaked at $1.28M in Q4 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Little House Capital's 13F filing for Q2 2026, filed 7 Aug 2026.